Diversity-Oriented Synthesis as a Strategy for Fragment Evolution against GSK3β

Yikai Wang1, Jean-Yves Wach1, Patrick Sheehan1

  • 1Chemical Biology Program, The Broad Institute of Harvard and MIT , 415 Main Street, Cambridge, Massachusetts 02142, United States.

Summary

Diversity-oriented synthesis (DOS) offers a novel fragment-based drug discovery (FBDD) strategy. This approach successfully identified initial hits against GSK3β and enabled the development of more potent compounds through analogue synthesis.

Related Concept Videos